IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma

被引：0
|
作者：
Cakir, F. B. [1 ]
Guler, B. [2 ]
Cay, A. [3 ]
Mirapoglu, S. [3 ]
Turkmen, A. Vehaboglu [4 ]
Aki, H. [5 ]
机构：
[1] Bezmialem Vakif Univ, Pediat Hematol Oncol, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Pathol, Istanbul, Turkey
[3] Bezmialem Vakif Univ, Pediat Surg, Istanbul, Turkey
[4] Bezmialem Vakif Univ, Pediat, Istanbul, Turkey
[5] Istanbul Univ, Pathol, Cerrahpasa Med Fac, Istanbul, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-228
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [1] Genetic landscape and prognostic value of IRF4 alterations in diffuse large B cell lymphoma patients
    Chen, X.
    Qin, Y.
    Xie, Z.
    Yang, J.
    Yang, S.
    Gui, L.
    Shi, Y-K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1601 - S1601
  • [2] Disruption of IRF4 in pediatric diffuse large B-cell lymphoma
    Sanmann, Jennifer N.
    Iqbal, Javeed
    Althof, Pamela A.
    Livermore, Chestnut A.
    Siebert, Reiner
    Sanger, Warren G.
    Chan, Wing C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 59 - 59
  • [3] Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population
    Hesius, Eva A. M.
    van Laar, Lidia
    Oosterveld, Margriet
    van Spriel, Annemiek B.
    Scheijen, Blanca
    Leeuwis, Jan Willem
    Marres, Henri A. M.
    Groenen, Patricia J. T. A.
    Stevens, Wendy B. C.
    van Der Spek, Ellen
    van den Brule, Adriaan J. C.
    Hoevenaars, Brigiet M.
    Hebeda, Konnie M.
    van den Brand, Michiel
    HISTOPATHOLOGY, 2023, 82 (07) : 1013 - 1020
  • [4] LARGE B-CELL LYMPHOMA WITH IRF4 REARRANGEMENT
    Plastinina, L., V
    Moiseeva, T. N.
    Al-Radi, L. S.
    Kovrigina, A. M.
    Obukhova, T. N.
    Goryacheva, S. R.
    Shupletsova, I. A.
    Magomedova, A. U.
    Kravchenko, S. K.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (03): : 445 - 457
  • [5] IRF4 Expression without IRF4 Rearrangement Is a General Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
    Pham-Ledard, Anne
    Prochazkova-Carlotti, Martina
    Vergier, Beatrice
    Petrella, Tony
    Grange, Florent
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (05) : 1470 - 1472
  • [6] DIRECT ANTIGLOBULIN TEST POSITIVITY IS A PROGNOSTIC MARKER IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
    Tobin, J.
    Shadbolt, B.
    Jain, S.
    Gonzalez, Y.
    Talaulikar, D.
    HAEMATOLOGICA, 2015, 100 : 394 - 394
  • [7] Large B-Cell Lymphoma With IRF4 Rearrangement Involving Lung
    Li, C.
    Teruya, B.
    Bhavana, D.
    Althof, P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S152 - S153
  • [8] Early pattern of large B-cell lymphoma with IRF4 rearrangement
    Granai, Massimo
    Lazzi, Stefano
    BLOOD, 2020, 136 (06) : 769 - 769
  • [9] Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients
    Yuan, Ji
    Liu, Hui
    Hu, Shimin
    Miranda, Roberto N.
    Xu, Xinjie
    Bayerl, Michael G.
    Artymiuk, Cody J.
    Berg, Holly
    King, Rebecca L.
    Shi, Min
    He, Rong
    Viswanatha, David
    Medeiros, L. Jeffrey
    Mcphail, Ellen D.
    HUMAN PATHOLOGY, 2023, 141 : 22 - 29
  • [10] RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
    Wu, Xue
    Li, Yuan
    Zhang, Wandong
    Zhang, Jing
    Chen, Baoan
    Ge, Zheng
    CELLS, 2022, 11 (24)
12345